Skip to main navigation
About us
Our Approach
Our Pipeline
Patients
Investors
Careers
About us
Our Approach
Our Pipeline
Patients
Investors
Careers
Overview
Corporate Presentation
Overview
News & Events
News Releases
Events
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Governance Overview
Board of Directors
Leadership
Financial Information
SEC Filings
SEC Filings - AGLE
Quarterly Results
IR Resources
Investor FAQs
Email Alerts
Contact IR

SEC Filing Details

Document Details

Form
8-K
Filing Date
Nov 24, 2023
Document Date
Nov 21, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Spyre Therapeutics
Issuer
SPYRE THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
  • Our Approach
  • Approach
  • Therapeutic Targets
  • Half-life Extension
  • Rational Combinations
  • Publications
  • Our Programs
  • Pipeline
  • Programs
  • Investors
  • Corporate Presentation
  • Overview
  • News & Events
  • Stock Information
  • Financial Information
  • Corporate Governance
  • IR Resources
  • Patients
  • Spyre Commitment
  • Clinical Trials & Disease Ed
  • Careers
  • Values
  • Benefits
  • Careers
  • About Us
  • People
  • Contact
Subscribe
to stay updated
  • Terms of Service
  • Privacy Policy
© 2026 Spyre Therapeutics. All rights reserved. For U.S. residents only.
Design and development by Visual Science